<p>Mock- and OVA-sensitized mice were inoculated with 10<sup>7</sup> PFU of a purified stock of WR with OVA in PBS, sacrificed at indicated days p.i, and skin biopsies were taken. (A) Size of primary lesions 7 days p.i. Data represent mean +/− S.E.M. *P<0.05, **P<0.01. Results of 2 experiments with n = 6–9 mice in each group. (B) WR titers (PFU/ml) in the site of WR inoculation 7 days p.i.; median values are indicated. No statistically significant differences. Results of 1–2 independent experiments. (C) Time course of WR growth. Data represent mean +/− S.E.M.; n = 3–12 mice in each group. No statistically significant differences. Results of 3 and 2 independent experiments in Nc/Nga mice and Balb/c mice, respectively. (D) Site of primary ino...
<p>Data represent mean +/− S.E.M.; n = 2–5 mice in each group. ND, not determined. Statistically sig...
<p>Mice were housed either under conventional or SPF conditions and actively immunized with 200 µg M...
<p>Mice were housed either under conventional (n = 6) or SPF (n = 4) conditions and actively immuniz...
<p>Mock- (A, C) and OVA-sensitized (B, D) mice were mock-inoculated with OVA in PBS (A, B) or inocul...
B6HLA mice were administered ~5 × 107 CFUs of wildtype S. pyogenes MGAS8232 or the ΔhasA or ΔhasA + ...
(Ai) Representative images of dermonecrotic lesion size in mice (BALB/cJ) after 6 days postinfection...
<p>Median fluorescence intensity (MFI) values reflect levels of IgG against 25 <i>S</i>. <i>aureus</...
<p>The control group (C; white) was inoculated with 0.9% sterile saline (A). Significant differences...
<p>BABL/c mice (n = 10) were passively immunized intraperitoneally (IP) anti-AT mAb 2A3 (10 mg/kg) (...
<p>Adult, female C3H mice were pre-treated with vehicle or 6MMPr once daily for seven consecutive da...
<p>Mice were infected with <i>M. ulcerans</i> strain 98–912 and were left untreated (closed circles)...
<p>(<b>a</b>) Mice were sensitized i.p. with 10 µg OVA adsorbed to 1.5 mg Al(OH)<sub>3</sub> or with...
<p>(A) There was no difference in lesion size between C57Bl/6j (wild type) and TCR βδ (-/-) mice aft...
<p>Mice (n = 4) were immunized with the octa-valent vaccine containing IsaA-His<sub>6</sub>, LytM-Hi...
<p>(a) Mice sensitized with OVA and treated with PBS (“AD without ASIT”), (b) mice sensitized with O...
<p>Data represent mean +/− S.E.M.; n = 2–5 mice in each group. ND, not determined. Statistically sig...
<p>Mice were housed either under conventional or SPF conditions and actively immunized with 200 µg M...
<p>Mice were housed either under conventional (n = 6) or SPF (n = 4) conditions and actively immuniz...
<p>Mock- (A, C) and OVA-sensitized (B, D) mice were mock-inoculated with OVA in PBS (A, B) or inocul...
B6HLA mice were administered ~5 × 107 CFUs of wildtype S. pyogenes MGAS8232 or the ΔhasA or ΔhasA + ...
(Ai) Representative images of dermonecrotic lesion size in mice (BALB/cJ) after 6 days postinfection...
<p>Median fluorescence intensity (MFI) values reflect levels of IgG against 25 <i>S</i>. <i>aureus</...
<p>The control group (C; white) was inoculated with 0.9% sterile saline (A). Significant differences...
<p>BABL/c mice (n = 10) were passively immunized intraperitoneally (IP) anti-AT mAb 2A3 (10 mg/kg) (...
<p>Adult, female C3H mice were pre-treated with vehicle or 6MMPr once daily for seven consecutive da...
<p>Mice were infected with <i>M. ulcerans</i> strain 98–912 and were left untreated (closed circles)...
<p>(<b>a</b>) Mice were sensitized i.p. with 10 µg OVA adsorbed to 1.5 mg Al(OH)<sub>3</sub> or with...
<p>(A) There was no difference in lesion size between C57Bl/6j (wild type) and TCR βδ (-/-) mice aft...
<p>Mice (n = 4) were immunized with the octa-valent vaccine containing IsaA-His<sub>6</sub>, LytM-Hi...
<p>(a) Mice sensitized with OVA and treated with PBS (“AD without ASIT”), (b) mice sensitized with O...
<p>Data represent mean +/− S.E.M.; n = 2–5 mice in each group. ND, not determined. Statistically sig...
<p>Mice were housed either under conventional or SPF conditions and actively immunized with 200 µg M...
<p>Mice were housed either under conventional (n = 6) or SPF (n = 4) conditions and actively immuniz...